Since highly pathogenic avian influenza virus (HPAIV) spread to the island of South Georgia in the sub-Antarctic in 2023, its ...

Developed by British drugmaker GSK, RTS,S/AS01E in 2021 became the first malaria vaccine to be recommended by the World ...

Earlier this month, a group of Canadian researchers published early influenza data for the 2025-26 season, issuing a warning: ...

Hundreds of malaria patients enrolled in a phase 3 clinical trial in Gabon, West Africa, were successfully treated with a one ...

The number of measles cases nationwide has risen by 42 the in past week, the Centers for Disease Control and Prevention (CDC) ...

At three months, relative to controls, greater improvements in intervention recipients were also seen for depression and ...

Infection with the mpox virus (MPXV) confers strong immunity against future infection for up to two years, compared with ...

A large study of US adults 65 and older enrolled in Medicare finds that the risk of Guillain-Barre syndrome (GBS)—a rare ...

The onset of several conditions, including allergic rhinitis, viral infections, and ear infections, was also delayed after ...

The researchers found that RSV vaccination was 82.3% effective in protecting against hospital admission for participants with ...

In PAHO's Americas region, which includes the United States, measles cases have increased 30-fold in 2025 compared to 2024.

The adjusted incident rate ratio (IRR) for GBS post-RSV disease was 2.11, reflecting a slightly more than double risk. The ...